Children with SCD who have sleep issues, such as sustained low blood oxygen during sleep, require more healthcare resources, ...

Pociredir 12 mg dose has shown favorable safety and signs of efficacy in a Phase 1b trial of sickle cell disease (SCD).

The first patient with SCD has been dosed in a clinical trial of HBI-002, an experimental, low-dose liquid formulation of ...

Because sickle cell disease is a multisystemic disorder, it can result in a wide range of symptoms, explains columnist.

A student at Kennesaw State is helping develop a low-cost, light-based device to screen for stroke in children with sickle ...

The first patient with SCD has been dosed in a clinical trial of HBI-002, an experimental, low-dose liquid formulation of carbon monoxide.

Columnist Tito Oye struggles to describe the pain involved in a sickle cell crisis. She turns to social media to ask her followers for help.

Starting in 2025,a pricing model aims to make novel therapies more accessible to sickle cell patients in the US with limited resources.

The blood-separation device Spectra Optia, which has the ability to remove abnormal red blood cells from sickle cell patients, can efficiently and safely replace these cells with healthy red blood ...

Bluebird Bio’s Lyfgenia (lovotibeglogene autotemcel) — formerly lovo-cel — was cleared for SCD patients, ages 12 and older, with a history of vaso-occlusive events (VOEs). It was approved along with ...

Children with sickle cell disease can come together for a week of recreation and learning at Camp Hope in North Carolina.

Clinton Health Access Initiative will use award to expand access to SCD diagnostic tests and treatment in low- and middle-income countries.